74 related articles for article (PubMed ID: 22406264)
21. Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development.
Chen L; Nakai M; Belton RJ; Nowak RA
Reproduction; 2007 Feb; 133(2):405-14. PubMed ID: 17307908
[TBL] [Abstract][Full Text] [Related]
22. Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion.
Ou W; Silver J
Virology; 2006 Jul; 350(2):406-17. PubMed ID: 16507315
[TBL] [Abstract][Full Text] [Related]
23. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
Kim SY; Kim DH; Han SJ; Hyun JW; Kim HS
Biochem Pharmacol; 2007 Dec; 74(11):1642-51. PubMed ID: 17880928
[TBL] [Abstract][Full Text] [Related]
24. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
Nie J; Pei D
Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
[TBL] [Abstract][Full Text] [Related]
25. The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist.
Roeb E; Schleinkofer K; Kernebeck T; Pötsch S; Jansen B; Behrmann I; Matern S; Grötzinger J
J Biol Chem; 2002 Dec; 277(52):50326-32. PubMed ID: 12384502
[TBL] [Abstract][Full Text] [Related]
26. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
[TBL] [Abstract][Full Text] [Related]
27. Bacitracin inhibits the reductive activity of protein disulfide isomerase by disulfide bond formation with free cysteines in the substrate-binding domain.
Dickerhof N; Kleffmann T; Jack R; McCormick S
FEBS J; 2011 Jun; 278(12):2034-43. PubMed ID: 21481187
[TBL] [Abstract][Full Text] [Related]
28. Biomolecular basis of matrix metallo proteinase-9 activity.
Swetha R; Gayen C; Kumar D; Singh TD; Modi G; Singh SK
Future Med Chem; 2018 May; 10(9):1093-1112. PubMed ID: 29676173
[TBL] [Abstract][Full Text] [Related]
29. Identification of hepsin and protein disulfide isomerase A3 as targets of gelatinolytic action in rat ovarian granulosa cells during the periovulatory period.
Rosewell K; Al-Alem L; Li F; Kelty B; Curry TE
Biol Reprod; 2011 Oct; 85(4):858-66. PubMed ID: 21734266
[TBL] [Abstract][Full Text] [Related]
30. Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain.
Farina AR; Cappabianca L; Di Ianni N; Ruggeri P; Ragone M; Merolle S; Gulino A; Mackay AR
FEBS Lett; 2012 Jul; 586(16):2366-74. PubMed ID: 22677171
[TBL] [Abstract][Full Text] [Related]
31. Classically activated macrophages use stable microtubules for matrix metalloproteinase-9 (MMP-9) secretion.
Hanania R; Sun HS; Xu K; Pustylnik S; Jeganathan S; Harrison RE
J Biol Chem; 2012 Mar; 287(11):8468-83. PubMed ID: 22270361
[TBL] [Abstract][Full Text] [Related]
32. The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors.
Van den Steen PE; Van Aelst I; Hvidberg V; Piccard H; Fiten P; Jacobsen C; Moestrup SK; Fry S; Royle L; Wormald MR; Wallis R; Rudd PM; Dwek RA; Opdenakker G
J Biol Chem; 2006 Jul; 281(27):18626-37. PubMed ID: 16672230
[TBL] [Abstract][Full Text] [Related]
33. Signatures of positive selection at hemopexin (PEX) domain of matrix metalloproteinase-9 (MMP-9) gene.
Liu Y; Zhao Y; Lu C; Fu M; Dou T; Tan X
J Biosci; 2015 Dec; 40(5):885-90. PubMed ID: 26648034
[TBL] [Abstract][Full Text] [Related]
34. Development of in-cell imaging assay systems for MMP-2 and MMP-9 based on trans-localizing molecular beacon proteins.
Lee MJ; Cho YA; Hwang HJ; Kim JH
Arch Pharm Res; 2015 Jun; 38(6):1099-107. PubMed ID: 25564338
[TBL] [Abstract][Full Text] [Related]
35. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9).
Van den Steen PE; Dubois B; Nelissen I; Rudd PM; Dwek RA; Opdenakker G
Crit Rev Biochem Mol Biol; 2002 Dec; 37(6):375-536. PubMed ID: 12540195
[TBL] [Abstract][Full Text] [Related]
36. Halogen bonding controls selectivity of FRET substrate probes for MMP-9.
Tranchant I; Vera L; Czarny B; Amoura M; Cassar E; Beau F; Stura EA; Dive V
Chem Biol; 2014 Mar; 21(3):408-13. PubMed ID: 24583051
[TBL] [Abstract][Full Text] [Related]
37. Engineering autoactivating forms of matrix metalloproteinase-9 and expression of the active enzyme in cultured cells and transgenic mouse brain.
Fisher KE; Fei Q; Laird ER; Stock JL; Allen MR; Sahagan BG; Strick CA
Biochemistry; 2002 Jul; 41(26):8289-97. PubMed ID: 12081477
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of damage associated SNPs of MMP9 gene: A computational approach.
Bhatnager R; Bhasin M; Dang AS
Comput Biol Chem; 2018 Dec; 77():97-108. PubMed ID: 30248431
[TBL] [Abstract][Full Text] [Related]
39. Identification of matrix metalloproteinase 9-interacting sequences in staphylococcal superantigen-like protein 5.
Kohno K; Itoh S; Hanai A; Takii T; Fujiwara T; Onozaki K; Tsuji T; Hida S
Biochem Biophys Res Commun; 2018 Mar; 497(2):713-718. PubMed ID: 29462623
[TBL] [Abstract][Full Text] [Related]
40. Structural basis of the adaptive molecular recognition by MMP9.
Cha H; Kopetzki E; Huber R; Lanzendörfer M; Brandstetter H
J Mol Biol; 2002 Jul; 320(5):1065-79. PubMed ID: 12126625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
